Dynamic Modeling of the Angiogenic Switch and Its Inhibition by Bevacizumab

Figure 2

(a) The measured tumor volumes for mice C1-C5 that received therapy 1 and their average. (b) The measured tumor volumes for mice E1-E9 that received therapy 2 and their average.

(a)

(b)